These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8724406)

  • 21. Dynamic contrast-enhanced breath-hold MR imaging of thoracic malignancy using cardiac compensation.
    Low RN; Sigeti JS; Song SY; Shimakawa A; Pelc NJ
    J Magn Reson Imaging; 1996; 6(4):625-31. PubMed ID: 8835956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of hepatic neoplasms: spin echo versus gadolinium-diethylenetriaminepentaacetate-enhanced gradient echo imaging.
    Abbas YA; Kressel HY; Wehrli FW; Gefter WB; Dinsmore BJ; Chan TW; Oleaga L; Milestone BN; Outwater EK
    Magn Reson Q; 1991 Oct; 7(4):275-92. PubMed ID: 1790113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement effects of hepatic dynamic MR imaging at 3.0 T and 1.5 T using gadoxetic acid in a phantom study: comparison with gadopentetate dimeglumine.
    Morita K; Namimoto T; Awai K; Komi M; Hashida M; Tsuji T; Hirai T; Yamashita Y
    Magn Reson Med; 2011 Jul; 66(1):213-8. PubMed ID: 21254212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lesion enhancement in radio-frequency spoiled gradient-echo imaging: theory, experimental evaluation, and clinical implications.
    Rand S; Maravilla KR; Schmiedl U
    AJNR Am J Neuroradiol; 1994 Jan; 15(1):27-35. PubMed ID: 8141062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial-phase three-dimensional contrast-enhanced MR angiography of the carotid arteries.
    Levy RA; Prince MR
    AJR Am J Roentgenol; 1996 Jul; 167(1):211-5. PubMed ID: 8659374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Morphologic MR imaging with T1-weighted sequences for radiotherapy goal volume definition of intracranial tumors. Comparison with FLASH-Turbo-FLASH and SE sequences].
    Hawighorst H; Knopp MV; Debus J; Brix G; Engenhart-Cabillic R; Schad LR; Grandy M; Essig M; van Kaick G
    Radiologe; 1997 Mar; 37(3):243-50. PubMed ID: 9182315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging.
    Soyer P; de Givry SC; Gueye C; Lenormand S; Somveille E; Scherrer A
    AJR Am J Roentgenol; 1996 May; 166(5):1115-21. PubMed ID: 8615254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular complications of pancreatic transplantation: MR evaluation.
    Krebs TL; Daly B; Wong JJ; Chow CC; Bartlett ST
    Radiology; 1995 Sep; 196(3):793-8. PubMed ID: 7644645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
    Johansson L; Kirchin MA; Ahlström H
    Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3T.
    Crombé A; Saranathan M; Ruet A; Durieux M; de Roquefeuil E; Ouallet JC; Brochet B; Dousset V; Tourdias T
    AJNR Am J Neuroradiol; 2015 Mar; 36(3):501-7. PubMed ID: 25376810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of optimized gadolinium-enhanced fast fluid-attenuated inversion recovery MR imaging in revealing lesions of the brain.
    Melhem ER; Bert RJ; Walker RE
    AJR Am J Roentgenol; 1998 Sep; 171(3):803-7. PubMed ID: 9725320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination.
    Wetzel SG; Johnson G; Tan AG; Cha S; Knopp EA; Lee VS; Thomasson D; Rofsky NM
    AJNR Am J Neuroradiol; 2002; 23(6):995-1002. PubMed ID: 12063232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of gadopentetate dimeglumine-enhanced, high-resolution magnetic resonance imaging to differentiate among melanin-containing skin tumors.
    Mäurer J; Schlums D; Knollmann FD; Garbe C; Vogl TJ; Bier J; Felix R
    Acad Radiol; 1996 Mar; 3(3):186-91. PubMed ID: 8796663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study].
    Essig M; Hartmann M; Lodemann KP; Jansen O; Seeberg A; Runge VM; Knopp MV
    Radiologe; 2001 Dec; 41(12):1063-71. PubMed ID: 11793931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease.
    Turkat TJ; Klein BD; Polan RL; Richman RH
    J Magn Reson Imaging; 1994; 4(4):563-8. PubMed ID: 7949682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
    Pui MH; Goh PS; Choo HF; Fok EC
    Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.